Zaramella P, Zorzi C, Pavanello L, Rizzoni G, Zacchello G, Rubaltelli F F, Cantarutti F
Department of Pediatrics, University of Padova, Italy.
Child Nephrol Urol. 1991;11(1):15-9.
We evaluated 38 newborns with acute renal failure (plasma creatinine (Pcr) concentration greater than = 1.5 mg/dl), measured between the 2nd and 5th days. We used renal ultrasound to exclude the possibility of congenital renal anomalies, obstructive pathology or vascular disorders. We calculated the glomerular filtration rate (GFR) using Schwartz' formula and the maximal concentrating capacity using intranasal administration of desamino-cis-1-D-arginine-8-vasopressin (DDAVP test). Two newborns were treated with peritoneal dialysis and died during the first month of life. Thirty-six had a follow-up blood sample drawn: 24 preterm babies between 1 and 12 months, and 12 full-term babies between 1 and 36 months of life. From this sampling 4 babies (11.1%) showed defective maximal concentrating ability. Our data reveal the persistence of altered concentrating ability in newborns affected by renal failure and shows that this problem needs a longitudinal study and further diagnostic investigations.
我们评估了38例在出生后第2天至第5天期间血浆肌酐(Pcr)浓度≥1.5mg/dl的急性肾衰竭新生儿。我们采用肾脏超声检查以排除先天性肾脏异常、梗阻性病变或血管疾病的可能性。我们使用施瓦茨公式计算肾小球滤过率(GFR),并通过经鼻给予去氨基-顺-1-D-精氨酸-8-加压素(DDAVP试验)来测定最大浓缩能力。两名新生儿接受了腹膜透析治疗,并在出生后第一个月内死亡。36例新生儿进行了随访血样采集:24例早产儿在出生后1至12个月,12例足月儿在出生后1至36个月。在该样本中,4例婴儿(11.1%)显示最大浓缩能力存在缺陷。我们的数据揭示了受肾衰竭影响的新生儿中浓缩能力改变的持续性,并表明这个问题需要进行纵向研究和进一步的诊断性调查。